NSE · ARVEE · Basic Materials
Arvee Laboratories (India) Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹39 Cr with net profit ₹2 Cr — a 5.49% net margin, versus 3.39% the period before.
Shareholding
As of 2026-06-30
- Promoter73.5%
- Public26.5%
1,596 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.25× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Specialty Chemicals · ranked #1 of 18 by market cap · medians across 1 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Sudarshan Colorants India Ltd. | ₹835 Cr | 17.31 | 1.47 | 7.81% | 5.7% |
| Arvee Laboratories (India) Ltd.(this company) | — | 335.7 | 5.15 | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashArvee Laboratories (India) Ltd. is listed with a market capitalization of Rs 174 Cr. The company reported a revenue of Rs 39.14 Cr for the latest financial year, with a profit margin of 8.03%. The debt-to-equity ratio stands at 0.03.
Positives
- +The company has a low debt-to-equity ratio of 0.03.
- +Promoter holding is high at 73.50% as of March 31, 2026.
- +There is no promoter share pledge reported.
Negatives
- −Revenue declined from Rs 62.70 Cr in March 2023 to Rs 39.14 Cr in March 2025.
- −The Profit Margin of 8.03% is relatively moderate.
- −Return on Equity (ROE) is 7.48% and Return on Capital Employed (ROCE) is 7.57%, which are below typical industry benchmarks.
- −Earnings per share (EPS) decreased from Rs 3.74 in March 2023 to Rs 1.95 in March 2025.
- −Quarterly net profit was Rs 0.01 Cr in September 2025, which is notably low.
Financial Performance
The company's revenue for the fiscal year ending March 2025 was Rs 39.14 Cr. Net profit for the same period was Rs 2.147 Cr, with an Earnings Per Share (EPS) of Rs 1.95. This marks a rebound from the previous fiscal year, where revenue was Rs 30.98 Cr and net profit was Rs 1.05 Cr in March 2024. However, revenue in March 2023 was higher at Rs 62.70 Cr, with a net profit of Rs 4.12 Cr.
Profitability & Returns
For the latest reported period, Arvee Laboratories (India) Ltd. achieved a profit margin of 8.03%. The Return on Equity (ROE) was 7.48%, and the Return on Capital Employed (ROCE) was 7.57%. The EPS for the trailing twelve months was Rs 2.29.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.03, indicating limited reliance on debt financing. The book value per share is Rs 30.66. There are no reported pledges by the promoters.
Ownership & Pledges
As of March 31, 2026, the promoter holding in Arvee Laboratories (India) Ltd. stands at 73.50%. The public shareholding is 26.50%. There is no pledged promoter holding, and no institutional ownership by FIIs or DIIs has been reported for this period.
Quarterly Performance
In the quarter ending March 2026, the company reported a revenue of Rs 10.8 Cr and a net profit of Rs 0.52 Cr. This follows a revenue of Rs 9.78 Cr and a net profit of Rs 1.83 Cr in the December 2025 quarter. The September 2025 quarter saw a revenue of Rs 3.45 Cr and a net profit of Rs 0.01 Cr.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Arvee Laboratories (India) Ltd.share price & fundamentals